,
,
,
,
,
,
,
,
,
,
,
,
The significance of caudate volume for age-related associative memory decline, Brain Res, vol.1622, pp.137-148, 2015. ,
Automated striatal uptake analysis of 18 F-FDOPA PET images applied to Parkinson's disease patients, 2011. ,
, Ann. Nucl. Med, vol.25, pp.796-803
Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren, Ann. Neurol, vol.36, pp.667-670, 1994. ,
18F-FDOPA PET for the diagnosis of parkinsonian syndromes, Q. J. Nucl. Med. Mol. Imaging Off. Publ. Ital. Assoc. Nucl. Med. AIMN Int. Assoc. Radiopharmacol. IAR Sect. Soc. Of, vol.58, pp.355-365, 2014. ,
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI, Neurology, vol.72, pp.1906-1913, 2009. ,
Striatal 18F-dopa uptake: absence of an aging effect, J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab, vol.13, pp.881-888, 1993. ,
Voxelbased analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects, Eur. J. Nucl. Med. Mol. Imaging, vol.39, pp.1778-1783, 2012. ,
High consistency of regional cortical thinning in aging across multiple samples, Cereb. Cortex N. Y. N, 2001. ,
Anterior cingulate dopamine turnover and behavior change in Parkinson's disease, Brain Imaging Behav, vol.9, pp.821-827, 2015. ,
Rate of 6-[18F]fluoro-L-dopa uptake decline in striatal subregions in Parkinson's disease, Mov. Disord. Off. J. Mov. Disord. Soc, vol.26, pp.614-620, 2011. ,
, , 2013.
, Rev. Espanola Med. Nucl. E Imagen Mol, vol.32, pp.350-356
Dopamine transporters in the cerebellum of mutant mice, Cerebellum Lond. Engl, vol.4, pp.105-111, 2005. ,
Influence of the normalization template on the outcome of statistical parametric mapping of PET scans, NeuroImage, vol.19, pp.601-612, 2003. ,
Preservation of limbic and paralimbic structures in aging, Hum. Brain Mapp, vol.25, pp.391-401, 2005. ,
The Effects of Carbidopa Administration on 6-[18F]Fluoro-L-DOPA Kinetics in Positron Emission Tomography, J. Nucl. Med, vol.33, pp.1472-1477, 1992. ,
Dopaminergic meso-cortical projections to m1: role in motor learning and motor cortex plasticity. Front. Neurol. 4, p.145, 2013. ,
Distributed modular architectures linking basal ganglia, cerebellum, and cerebral cortex: their role in planning and controlling action, Cereb. Cortex N. Y. N, vol.5, pp.95-110, 1991. ,
Brain reward circuitry beyond the mesolimbic dopamine system: A neurobiological theory, Neurosci. Biobehav. Rev, vol.35, pp.129-150, 2010. ,
Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders, Nucl. Med. Commun, vol.34, pp.426-431, 2013. ,
Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.50, pp.893-899, 2009. ,
Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction, J. Neurol. Sci, vol.329, pp.23-28, 2013. ,
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease, Brain J. Neurol, vol.136, pp.2419-2431, 2013. ,
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects, Biol. Psychiatry, vol.52, pp.759-763, 2002. ,
A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa uptake in Parkinson's disease, vol.68, pp.325-331, 2014. ,
Healthy aging: an automatic analysis of global and regional morphological alterations of human brain, Acad. Radiol, vol.19, pp.785-793, 2012. ,
Alzheimer's Disease Neuroimaging Initiative, 2010. 3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects, Neurobiol. Aging, vol.31, pp.1312-1325 ,
Nigrostriatal function in humans studied with positron emission tomography, Ann. Neurol, vol.26, pp.535-542, 1989. ,
Absorbed dose to the adult male and female brain from 18F-fluorodeoxyglucose, Health Phys, vol.80, pp.62-66, 2001. ,
Sex differences in brain-behavior relationships between verbal episodic memory and resting regional cerebral blood flow, Neuropsychologia, vol.38, pp.451-461, 2000. ,
Striatal function in normal aging: implications for Parkinson's disease, Ann. Neurol, vol.28, pp.799-804, 1990. ,
Partial-volume effect in PET tumor imaging, J. Nucl. Med. Off. Publ. Soc. Nucl. Med, vol.48, pp.932-945, 2007. ,
Mapping cortical change across the human life span, Nat. Neurosci, vol.6, pp.309-315, 2003. ,
(18)F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison, Am. J. Nucl. Med. Mol. Imaging, vol.2, pp.475-482, 2012. ,
Correlations among brain gray matter volumes, age, gender, and hemisphere in healthy individuals, PloS One, vol.6, 2011. ,
Age-related changes in FDG brain uptake are more accurately assessed when applying an adaptive template to the SPM method of voxel-based quantitative analysis, Ann. Nucl. Med, vol.29, pp.921-928, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01245045
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis, Eur. J. Nucl. Med. Mol. Imaging, vol.40, pp.213-227, 2013. ,
Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology, Hum. Brain Mapp, vol.28, pp.228-237, 2007. ,
DOI : 10.1002/hbm.20273
Age, sex and laterality effects on cerebral glucose metabolism in healthy adults, Psychiatry Res, vol.114, pp.23-37, 2002. ,
Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve, Psychiatry Res, vol.221, pp.78-85, 2014. ,
, Ses principales limites sont qu'il ne s'agit pas de sujets "sains" à proprement parler, car, bien que dénué de pathologie neuro-oncologique ou neurodégénérative dopaminergique connue, ces sujets sont issus de l'acquisition d'images provenant de patient atteint de pathologie tumorale (neuro-endocrine) pour la plupart ; qu'il est issu d'acquisitions corps entier, et de ce fait, bien que très similaire en termes de coups à une acquisition cérébrale
Projected number of people with Parkinson disease in the most populous nations, Neurology, vol.68, issue.5, pp.384-390, 2005. ,
Challenges of modifying disease progression in prediagnostic Parkinson's disease, Lancet Neurol, vol.15, issue.6, pp.637-685, 2016. ,
Parkinson's disease, Lancet Lond Engl, vol.386, issue.9996, pp.896-912, 2015. ,
Parkinson's Disease and Parkinsonism: Neuropathology. Cold Spring Harb Perspect Med, vol.2, 2012. ,
Physiology and pathophysiology of Parkinson's disease, Ann N Y Acad Sci, vol.991, pp.15-21, 2003. ,
18F-FDOPA PET for the diagnosis of parkinsonian syndromes, Q J Nucl Med Mol Imaging Off Publ Ital Assoc Nucl Med AIMN Int Assoc Radiopharmacol IAR Sect Soc Of, 2014. ,
Brain reward circuitry beyond the mesolimbic dopamine system: A neurobiological theory, Neurosci Biobehav Rev, vol.35, issue.2, pp.129-50, 2010. ,
, Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, 2009.
Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway, Mol Chem Neuropathol, vol.14, issue.3, pp.153-97, 1991. ,
Parkinson's disease, Lancet Lond Engl, vol.363, issue.9423, pp.1783-93, 2004. ,
Parkinson disease. Nat Rev Dis Primer, vol.3, p.17013, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-00391622
A voxelbased morphometric study of ageing in 465 normal adult human brains, NeuroImage, vol.14, issue.1, pp.21-36, 2001. ,
Imaging in Parkinson's Disease, Int Rev Neurobiol, vol.132, pp.233-74, 2017. ,
A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry, J Neurol Neurosurg Psychiatry, vol.78, issue.3, pp.254-263, 2007. ,
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls, Brain J Neurol, vol.127, pp.791-800, 2004. ,
Grey matter atrophy in cognitively impaired Parkinson's disease, J Neurol Neurosurg Psychiatry, vol.83, issue.2, pp.188-94, 2012. ,
DOI : 10.1136/jnnp-2011-300828
Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson's Disease, PLOS ONE, vol.8, issue.1, p.54980, 2013. ,
Temporal lobe atrophy on MRI in Parkinson disease with dementia A comparison with Alzheimer disease and dementia with Lewy bodies, Neurology, vol.64, issue.5, pp.861-866, 2005. ,
Neurodegeneration Across Stages of Cognitive Decline in Parkinson Disease, Arch Neurol, vol.68, issue.12, pp.1562-1570, 2011. ,
Cortical thinning is associated with disease stages and dementia in Parkinson's disease, J Neurol Neurosurg Psychiatry, vol.84, issue.8, pp.875-81, 2013. ,
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia, Mov Disord, vol.25, issue.6, pp.687-95, 2010. ,
DOI : 10.1002/mds.22799
URL : http://europepmc.org/articles/pmc3068920?pdf=render
Parkinson's disease is associated with hippocampal atrophy, Mov Disord, vol.18, issue.7, pp.784-90, 2003. ,
DOI : 10.1002/mds.10444
Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia, Mov Disord, vol.20, issue.5, pp.540-544, 2005. ,
Imaging insights into basal ganglia function, Parkinson's disease, and dystonia, Lancet Lond Engl, vol.384, issue.9942, pp.532-576, 2009. ,
DOI : 10.1016/s0140-6736(14)60041-6
URL : http://europepmc.org/articles/pmc4454525?pdf=render
Neuroimaging in Parkinson disease: from research setting to clinical practice, Nat Rev Neurol, vol.10, issue.12, pp.708-730, 2014. ,
DOI : 10.1038/nrneurol.2014.205
Dopamine Transporter (DaT) SPECT Imaging, vol.6, 2012. ,
Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET, J Nucl Med Off Publ Soc Nucl Med, vol.37, issue.11, pp.1760-1765, 1996. ,
Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease ,
, Eur J Nucl Med Mol Imaging, vol.33, issue.2, pp.200-209, 2006.
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls, Eur J Nucl Med Mol Imaging, vol.36, issue.3, pp.454-62, 2009. ,
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes, Clin Physiol Funct Imaging, 2016. ,
6-L18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications, J Nucl Med Off Publ Soc Nucl Med, 2008. ,
Pitfalls and Limitations of PET/CT in Brain Imaging, p.2017 ,
Nonlinear Progression of Parkinson Disease as Determined by Serial Positron Emission Tomographic Imaging of Striatal Fluorodopa F 18 Activity, Arch Neurol, vol.62, issue.3, pp.378-82, 2005. ,
Dementia in Parkinson disease Functional imaging of cholinergic and dopaminergic pathways, Neurology, vol.65, issue.11, pp.1716-1738, 2005. ,
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study, Brain, vol.132, issue.11, pp.2970-2979, 2009. ,
FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines, Eur J Nucl Med Mol Imaging, vol.34, issue.7, pp.1131-1132, 2007. ,
Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine, Eur J Nucl Med Mol Imaging, vol.30, issue.11, pp.1561-1568, 2003. ,
DOI : 10.1007/s00259-003-1259-1
F-Dopa as an amino acid tracer to detect brain tumors, J Nucl Med Off Publ Soc Nucl Med, vol.37, issue.7, pp.1180-1182, 1996. ,
The Effects of Carbidopa Administration on 6-[18F]Fluoro-L-DOPA Kinetics in Positron Emission Tomography, J Nucl Med, vol.33, issue.8, pp.1472-1479, 1992. ,
Fluorine-18-Fluoro-L-DOPA Dosimetry with Carbidopa Pretreatment, J Nucl Med, 1998. ,
, Nov, vol.1, issue.11, pp.1884-91
Agerelated changes in FDG brain uptake are more accurately assessed when applying an adaptive template to the SPM method of voxel-based quantitative analysis, Ann Nucl Med, vol.29, issue.10, pp.921-929, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01245045
Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping, NeuroImage, vol.9, issue.1, pp.63-80, 1999. ,
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains, J Nucl Med Off Publ Soc Nucl Med, 2001. ,
,
, Rev Espanola Med Nucl E Imagen Mol, vol.32, pp.350-356, 2013.
Influence of the normalization template on the outcome of statistical parametric mapping of PET scans, NeuroImage, vol.19, issue.3, pp.601-613, 2003. ,
Validation of a standardized normalization template for statistical parametric mapping analysis of 123IFP-CIT images, J Nucl Med Off Publ Soc Nucl Med, vol.48, issue.9, pp.1459-67, 2007. ,
Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects, Eur J Nucl Med Mol Imaging, vol.39, issue.11, pp.1778-83, 2012. ,
Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren, Ann Neurol, vol.36, issue.4, pp.667-70, 1994. ,
Striatal 18Fdopa uptake: absence of an aging effect, J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab, vol.13, issue.5, pp.881-889, 1993. ,
Striatal function in normal aging: implications for Parkinson's disease, Ann Neurol, 1990. ,
Nigrostriatal function in humans studied with positron emission tomography, Ann Neurol, vol.26, issue.4, pp.535-577, 1989. ,
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects, Biol Psychiatry, vol.52, issue.7, pp.759-63, 2002. ,
Distributed modular architectures linking basal ganglia, cerebellum, and cerebral cortex: their role in planning and controlling action, Cereb Cortex N Y N, vol.5, issue.2, pp.95-110, 1991. ,
DOI : 10.1093/cercor/5.2.95
The significance of caudate volume for age-related associative memory decline, Brain Res, vol.1622, pp.137-185, 2015. ,
3D maps localize caudate nucleus atrophy in 400 Alzheimer's disease, mild cognitive impairment, and healthy elderly subjects, Neurobiol Aging, vol.31, issue.8, pp.1312-1337, 2010. ,
Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve, Psychiatry Res, vol.221, issue.1, pp.78-85, 2014. ,
Sex differences in brainbehavior relationships between verbal episodic memory and resting regional cerebral blood flow, Neuropsychologia, vol.38, issue.4, pp.451-61, 2000. ,
Age, sex and laterality effects on cerebral glucose metabolism in healthy adults, Psychiatry Res, vol.114, issue.1, pp.23-37, 2002. ,
Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach, J Nucl Med Off Publ Soc Nucl Med, vol.43, issue.10, pp.1324-1354, 2002. ,
Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders, Nucl Med Commun, vol.34, issue.5, pp.426-457, 2013. ,
Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls, J Nucl Med Off Publ Soc Nucl Med, vol.50, issue.6, pp.893-902, 2009. ,
Carbidopaassisted (18)F-fluorodihydroxyphenylalanine PET/CT for the localization and staging of non-functioning neuroendocrine pancreatic tumors, Ann Nucl Med, vol.30, issue.9, pp.659-68, 2016. ,
The Effects of Carbidopa on Uptake of 6-18F-Fluoro-l-DOPA in PET of Pheochromocytoma and Extraadrenal Abdominal Paraganglioma, J Nucl Med, vol.48, issue.10, pp.1599-606, 2007. ,
High levels of dopamine activity in the basal ganglia of cigarette smokers, Am J Psychiatry, vol.157, issue.4, pp.632-636, 2000. ,
Cet article est soumis à publication (NeuroImage Clinical) et est accepté en présentation orale au congrès de l'European Association of Nuclear Medicine à Viennes en octobre, 2017. ,